Current status of biomarkers for prostate cancer
International Journal of Molecular Sciences, ISSN: 1422-0067, Vol: 14, Issue: 6, Page: 11034-11060
2013
- 179Citations
- 302Captures
- 6Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations179
- Citation Indexes178
- 178
- CrossRef162
- Patent Family Citations1
- Patent Families1
- Captures302
- Readers302
- 302
- Mentions6
- References3
- Wikipedia3
- News Mentions2
- News2
- Blog Mentions1
- Blog1
Most Recent Blog
5 Blood Biomarkers for Late-Stage Prostate Cancer
An aggressive form of prostate cancer is especially prevalent among African-American men, lending additional urgency to the search for biomarkers that allow earlier diagnosis and guide treatment. Current research is finding that, as with many other tumors, prostate cancer is characterized by heterogeneity among patients. Researchers are seeking reliable blood biomarkers to assess prognosis and tre
Most Recent News
Cancer Diagnosis by Multiparametric UltraSound of the Prostate; CADMUS
STUDY INFORMATION OFFICIAL TITLE: Multi-parametric Ultrasound Targeted Biopsies Compared to Multi-parametric MRI Targeted Biopsies in the Diagnosis of Clinically Significant Prostate Cancer CURRENT STATUS: Unknown
Review Description
Prostate cancer (PCa) is a leading cause of cancer-related death of men globally. Since its introduction, there has been intense debate as to the effectiveness of the prostate specific antigen (PSA) test as a screening tool for PCa. It is now evident that the PSA test produces unacceptably high rates of false positive results and is not prognostic. Here we review the current status of molecular biomarkers that promise to be prognostic and that might inform individual patient management. It highlights current efforts to identify biomarkers obtained by minimally invasive methods and discusses current knowledge with regard to gene fusions, mRNA and microRNAs, immunology, and cancer-associated microparticles. © 2013 by the authors; licensee MDPI, Basel, Switzerland.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84878438449&origin=inward; http://dx.doi.org/10.3390/ijms140611034; http://www.ncbi.nlm.nih.gov/pubmed/23708103; https://www.mdpi.com/1422-0067/14/6/11034; https://dx.doi.org/10.3390/ijms140611034; https://www.mdpi.com/1422-0067/14/6/11034/pdf?version=1403146436; https://www.mdpi.com/1422-0067/14/6/11034/htm; http://www.mdpi.com/1422-0067/14/6/11034/; http://www.mdpi.com/1422-0067/14/6/11034; https://www.mdpi.com/1422-0067/14/6/11034/pdf
MDPI AG
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know